SANTA BARBARA, CA / ACCESSWIRE / August 14, 2015 / As health plans and accountable care organizations (ACOs) across the United States review their colorectal cancer (CRC) screening practices, many of ...

Annual FIT-based screening produced fewer CRC cases, fewer CRC deaths and more life years gained versus all other strategies, even at real-world adherence rates. Every screening strategy that was ...

Helen Landicho, Senior Vice President of Regulatory Affairs has exuberantly stated, "I truly believe that because of the efforts by the Southeastern Colorectal Cancer Coalition, the Symposium will be ...

Polymedco, a manufacturer, marketer and distributor in the clinical laboratory space, has pledged support to the Colon Cancer Prevention Project, based in Louisville, Ky. Polymedco will lend support ...

CORTLANDT MANOR, N.Y., Jan. 30, 2024 /PRNewswire/ -- Polymedco, a leading provider of best-in-class colorectal cancer screening and early detection solutions, is proud to announce its membership in ...

Phenomenome Discoveries Inc. and Polymedco Cancer Diagnostic Products LLC. have announced a commercial licensing agreement for the US market, providing rights to Polymedco to commercialize PDI’s ...

CORTLANDT MANOR, N.Y., June 21, 2016 /PRNewswire/ -- Polymedco announced today that its OC-Auto® family of FIT products and Epi proColon® (Epigenomics) blood test for colorectal cancer screening have ...

LAKE FOREST, Ill., June 6, 2022 /PRNewswire/ -- RoundTable Healthcare Partners ("RoundTable"), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today ...

CORTLANDT MANOR, N.Y., April 11 /PRNewswire/ -- Polymedco, Inc. is pleased to announce the introduction of the PATHFAST immunoassay analyzer. The PATHFAST rapid point of care system utilizes a ...

Epigenomics AG has announced that Polymedco, Inc. reiterates its commitment to support Epi proColon(R) in the United States. Epi proColon(R) is Epigenomics' convenient blood-based test for colorectal ...

PATHFAST hs-cTnI-II becomes first and only hs-cTn test cleared for point-of-care use in the United States, delivering results up to three times faster than core lab testing CORTLANDT MANOR, N.Y., ...